Ferreira Juan J, Kent Lindsey N, McCarthy Ronald, Butler Alice, Ma Xiaofeng, Peramsetty Nikita, Amazu Chinwendu, Zhang Alexander, Whitter Grace C, Li Ethan, England Sarah K, Santi Celia M
Department of Obstetrics and Gynecology, Center for Reproductive Health Sciences, Washington University in St. Louis, School of Medicine, 425 S. Euclid Avenue, CB 8064, St. Louis, MO 63110, USA.
bioRxiv. 2025 Mar 9:2024.05.29.596465. doi: 10.1101/2024.05.29.596465.
At the end of pregnancy, the uterus transitions from a quiescent to a highly contractile state. This is partly due to depolarization of the resting membrane potential in uterine (myometrial) smooth muscle cells (MSMCs). In human MSMCs, the membrane potential is regulated by a functional complex between the sodium (Na)-activated potassium (K) channel SLO2.1 and the Na Leak Channel Non-Selective (NALCN). Na entering through NALCN activates SLO2.1, leading to K efflux, membrane hyperpolarization (cells become more negative inside), and reduced contractility. Decreased SLO2.1/NALCN activity results in reduced K efflux, leading to membrane depolarization, Ca influx via voltage-dependent calcium channels, and increased MSMC contractility. However, all of these data are from MSMCs isolated from women at term, so the role of the SLO2.1/NALCN complex early in pregnancy was speculative. To address this question here, we examined the role of the SLO2.1/NALCN complex in regulating mouse MSMC membrane potential across pregnancy. We report that and are more highly expressed in MSMCs from non-pregnant and early pregnant mice than in those from late-pregnant mice. Functional studies revealed that SLO2.1 channels mediate a significant portion of the K current in mouse MSMCs, particularly in cells from non-pregnant and early pregnant mice. Activation of SLO2.1 by Na influx through NALCN led to membrane hyperpolarization in MSMCs from early pregnancy but not in MSMCs from later pregnancy. Moreover, the NALCN/SLO2.1 complex regulates intracellular Ca responses more in MSMCs from non-pregnant and early pregnancy mice than in MSMCs from late pregnancy. Together, these findings reveal that the SLO2.1/NALCN functional complex is conserved between mouse and humans and functions throughout pregnancy. This work could open avenues for targeted pharmacological interventions for pregnancy-related complications.
在妊娠末期,子宫从静止状态转变为高度收缩状态。这部分是由于子宫(子宫肌层)平滑肌细胞(MSMCs)静息膜电位的去极化。在人类MSMCs中,膜电位由钠(Na)激活钾(K)通道SLO2.1和非选择性钠漏通道(NALCN)之间的功能复合物调节。通过NALCN进入的Na激活SLO2.1,导致K外流、膜超极化(细胞内变得更负)和收缩性降低。SLO2.1/NALCN活性降低导致K外流减少,导致膜去极化、通过电压依赖性钙通道的Ca内流以及MSMC收缩性增加。然而,所有这些数据均来自足月分娩女性分离的MSMCs,因此SLO2.1/NALCN复合物在妊娠早期的作用只是推测性的。为了解决这个问题,我们研究了SLO2.1/NALCN复合物在整个妊娠期调节小鼠MSMC膜电位中的作用。我们报告,SLO2.1和NALCN在未怀孕和怀孕早期小鼠的MSMCs中比在怀孕晚期小鼠的MSMCs中表达更高。功能研究表明,SLO2.1通道介导小鼠MSMCs中很大一部分K电流,特别是在未怀孕和怀孕早期小鼠的细胞中。通过NALCN使Na内流激活SLO2.1导致怀孕早期MSMCs膜超极化,但怀孕晚期MSMCs则不然。此外,NALCN/SLO2.1复合物在未怀孕和怀孕早期小鼠的MSMCs中比在怀孕晚期小鼠的MSMCs中对细胞内Ca反应的调节作用更大。总之,这些发现表明,SLO2.1/NALCN功能复合物在小鼠和人类之间是保守的,并且在整个妊娠期都发挥作用。这项工作可能为针对妊娠相关并发症的靶向药物干预开辟途径。